SCHEMBL29141982

SCHEMBL29141982

CCn1n[c]c2cc(F)ccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HTR2A P28223 3/20 0.35
HTR2C P28335 3/20 0.35
RPS6KA5 O75582 2/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
PLK1 P53350 1/20 0.32
PARK7 Q99497 1/20 0.32
TSHR P16473 1/20 0.32
CYP11B1 P15538 2/20 0.31
CYP11B2 P19099 2/20 0.31
KCNH2 Q12809 2/20 0.31
GRIA1 P42261 1/20 0.31
GRIA2 P42262 1/20 0.31
GRIA3 P42263 1/20 0.31
GRIA4 P48058 1/20 0.31
ADORA2A P29274 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23290037 0.86 HTR2C (0.35) KDM4EMAPTMAPK1L3MBTL1HTR2A
SCHEMBL8610877 0.77 MEN1 (0.35) KDM4EHTR2AHTR2CALDH1A1GAA
SCHEMBL29142064 0.72 HTR2C (0.35) HTR2AHTR2CCYP11B1CYP11B2KCNH2
SCHEMBL18323591 0.67 HCAR3 (0.58) MAPTALDH1A1
SCHEMBL24824382 0.67 HTR2A (0.65) KDM4EMAPTMAPK1L3MBTL1HTR2A
SCHEMBL8615623 0.66 ATM (0.34) KDM4EHTR2AHTR2CALDH1A1CYP11B1
SCHEMBL17232744 0.66 ADORA2A (0.62) KDM4EMAPTMAPK1L3MBTL1ALDH1A1
SCHEMBL29142030 0.65 RBP4 (0.32)
SCHEMBL15832959 0.64 KDM4E (0.41) KDM4EMAPTMAPK1L3MBTL1HTR2A
SCHEMBL21334032 0.64 KDM4E (0.41) KDM4EMAPTMAPK1L3MBTL1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117440774-A Biomarkers of age-related macular degeneration 倍亮生物有限责任公司 2024-01-23 CN disclosed
CN-114364382-A Formulations and methods of use of RBP4 inhibitors 倍亮生物有限责任公司 2022-04-15 CN disclosed